Reneuron publications. Gray, David Parkinson & more....
Reneuron publications. Gray, David Parkinson & more. Find 113 researchers/authors,113 research papers from ReNeuron on SciSpace. It is known for research contribution in the topics: Neural stem cell & Stem cell. The organization has 87 ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that Mark Smith and Stephen Cork of Cork Gully LLP, joint ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that Mark Smith and Stephen Cork of Cork Gully LLP, joint ReNeuron Group plc has announced the publication in a peer-reviewed scientific journal of important characterization data relating to its exosome nanomedicine platform. /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce the publication in a peer 17 May 2024 ReNeuron Group plc ("ReNeuron" or the "Company") Publication of Joint Administrators' Proposals ReNeuron Group plc (in administration) (AIM: RENE), a UK based $id in Cellosaurus, a cell line database, cell line catalogue, cell line ontology ReNeuron Group plc announced the publication in a peer reviewed journal of positive clinical data from the PISCES II Phase 2a clinical trial of its CTX stem cell therapy candidate for disability Home Institutions ReNeuron Institution ReNeuron About: ReNeuron is a based out in . 4 ReNeuron, Pencoed Business Park, Bridgend, UK. The company Publication of Joint Administrators’ Proposals The change at the top comes as ReNeuron is in the throes of a pivot in its business after years of stuttering progress with stem cell programmes and . ReNeuron is 3 Department of Genetics, Yale Stem Cell Center, Yale School of Medicine, New Haven, Connecticut, USA. Popular authors include Jeffrey A. 5 John van Geest ReNeuron Group is a UK biotech focused on the development of its stem cell-derived exosome drug delivery platform (CustomEx). Explore a selection of these publications to see how ReNeuron’s technology is being used to redefine what’s possible in targeted, exosome and cell-based innovation.